Humana IncHUM
Price$379.68Intrinsic value$367.843% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $367.84median of 6 methods · middle span $211-$410based on filings through 31 Mar 2026
Market Price $379.68Price as of 1 Oct 2026
Margin of Safety -3.1%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: -6.7% (near-term consensus, capped) · years 2–5: 21.2%/yr (balance of the path).15.0% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 617.5%Yr 713.9%Yr 810.3%Yr 96.6%Yr 103.0%
21.2% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)-11.2%
Discount rate (cost of equity) 8.6%
Volatility vs market (adjusted beta)0.82

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetHumana IncHUMHealth Care
Valuation
P/E40.5×
P/S7.5×
P/B2.5×
EV / Revenue8.9×
EV / EBITDA—
Profitability
Gross margin—
Operating margin39.6%
Net margin18.3%
FCF margin20.6%
Returns
ROE6.1%
ROA2.0%
ROIC4.1%
Growth
Revenue growth (YoY)39.4%
5-yr fwd EPS growth17.4%
Financial strength
Debt / Equity0.75×
Current ratio1.77×
Altman Z-Score2.1
Interest coverage—
Dividend yield0.7%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.